Sarah Diepstraten

Sarah Diepstraten completed her PhD at La Trobe University in molecular genetics and developmental biology. She is now a post-doctoral scientist at the Walter and Eliza Hall Institute. Her research focuses on understanding how blood cancers become resistant to therapy and how this can be overcome. She develops genetic engineering approaches (CRISPR) to find genes involved in drug resistance. She has also taught in undergraduate science courses at La Trobe University and Melbourne University, and is passionate about science education.